These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5037283)

  • 1. [Pharmacological research on the structure of adrenergic receptors in the heart].
    Gryglewski R
    Acta Physiol Pol; 1972; 23():23-42. PubMed ID: 5037283
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol.
    Petrack B; Czernik AJ
    Mol Pharmacol; 1976 Mar; 12(2):203-7. PubMed ID: 4723
    [No Abstract]   [Full Text] [Related]  

  • 3. [A common pool of adenylate cyclase for different types of afferent receptors].
    Zamboni P; Renna G; Paradiso M
    Boll Soc Ital Biol Sper; 1980 May; 56(9):925-31. PubMed ID: 6255976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
    Mayer SE
    J Pharmacol Exp Ther; 1972 Apr; 181(1):116-25. PubMed ID: 4335168
    [No Abstract]   [Full Text] [Related]  

  • 5. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
    Chen FC; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1982 Jul; 222(1):7-13. PubMed ID: 6283073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of adenylate cyclase in myocardial junctional sarcoplasmic reticulum. Cytochemical study after isoproterenol activation and propranolol inhibition of beta receptors.
    Slezak J; Geller SA; Shuman H
    Adv Myocardiol; 1982; 3():381-92. PubMed ID: 6302781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcellular myocardial effects of verapamil and D600: comparison with propranolol.
    Watanabe AM; Besch HR
    J Pharmacol Exp Ther; 1974 Nov; 191(2):241-51. PubMed ID: 4153724
    [No Abstract]   [Full Text] [Related]  

  • 9. [The nature of differences in beta-adrenergic receptors].
    Abrmets II; Simon IB
    Biull Eksp Biol Med; 1975 May; 79(5):11-4. PubMed ID: 1227580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenergic receptors and responses in the heart.
    Reuter H; Porzig H
    Postgrad Med J; 1981; 57 Suppl 1():62-70. PubMed ID: 6272252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors and acceptors: a necessary distinction in hormone binding studies.
    Birnbaumer L; Pohl SL; Kaumann AJ
    Adv Cyclic Nucleotide Res; 1974; 4(0):239-81. PubMed ID: 4369121
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenergic receptors of the heart.
    Mayer SE
    Neurosci Res Program Bull; 1973 Jun; 11(3):201-4. PubMed ID: 4351988
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological characterization of receptors: its relation to radioligand-binding studies.
    Furchgott RF
    Fed Proc; 1978 Feb; 37(2):115-20. PubMed ID: 203488
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological maturation and beta-adrenergic effectors: pre- and postnatal development of the adenylate cyclase system in the rabbit heart.
    Schumacher WA; Sheppard JR; Mirkin BL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):587-93. PubMed ID: 6292391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenyl cyclase and the differentiation of -adrenoreceptors.
    Burges RA; Blackburn KJ
    Nat New Biol; 1972 Feb; 235(60):249-50. PubMed ID: 4401711
    [No Abstract]   [Full Text] [Related]  

  • 17. (3H)-Propranolol binding sites in myocardial membranes: nonidentity with beta adrenergic receptors.
    Vatner DE; Lefkowitz RJ
    Mol Pharmacol; 1974 May; 10(3):450-6. PubMed ID: 4847937
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and pharmacological activity of 1-isopropylamino-3-(1-naphthylamino)-2-propanol, an analogue of propranolol.
    Daniewski W; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):23-8. PubMed ID: 4775863
    [No Abstract]   [Full Text] [Related]  

  • 19. [A model of the action of beta-mimetic substances (author's transl)].
    Weidinger H; Wiest W
    Z Geburtshilfe Perinatol; 1973 Aug; 177(4):223-32. PubMed ID: 4149059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of thyrotoxicosis on adrenergic receptors, cyclic adenosine monophosphate, glycogen and enzymes of the myocardium].
    Felt V; Nedvidková J; Hynie S; Mosinger B; Vavŕinková M
    Z Gesamte Inn Med; 1980 May; 35(10):395-400. PubMed ID: 6108021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.